FDA.reportPublic FDA data

Levoxyl 0.137 MG Oral Tablet

RxCUI
966194
RxNorm name
Levoxyl 0.137 MG Oral Tablet
Display name
Levoxyl 0.137 MG Oral Tablet
Full name
Levoxyl 0.137 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LEVOXYLLEVOTHYROXINE SODIUMPfizer Laboratories Div Pfizer Inc758588c3-c63e-491b-0aa2-4f50d80cb1742020-12-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966194

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
758588c3-c63e-491b-0aa2-4f50d80cb174LEVOXYL 137 MCG Oral Tablet [PSN] · levothyroxine sodium 0.137 MG Oral Tablet [Levoxyl] [SBD] · Levoxyl 0.137 MG Oral Tablet [SY] · Levoxyl 137 MCG Oral Tablet [SY]412These highlights do not include all the information needed to use LEVOXYL safely and effectively. See full prescribing information for LEVOXYL. LEVOXYL ® (levothyroxine sodium) tablets, for oral use Initial U.S. Approval: 200120201215